Researchers reveal a crucial process in the working of the immune system

VIB researchers show how dendritic cells mature without causing an immune response

Ghent, 15 May – For our immune system to initiate a response to an infection, cells called dendritic cells have to present antigens to T cells. This shows the T cells where to focus their efforts and helps clear the infection. In normal conditions, however, dendritic cells shouldn't activate the immune system or else autoimmune conditions arise. New work by the teams of profs. Yvan Saeys, Kodi Ravichandran, Bart Lambrecht, and Sophie Janssens (VIB-UGent Center for Inflammation Research) reveals how dendritic cells mature without causing an immune response. Their work appears in Science Immunology and has ramifications for the treatment of various autoimmune disorders.  

Raising the flag (in peacetime) 

Think of the immune system as an army with regiments of different cell types that have to work together to protect the rest of the body from bacterial or viral invaders. T cells are a group of diverse cells that we can consider as the infantry of our immune army. But they have to learn how to recognize the invaders first. 

That's where the dendritic cells (or DCs) come in. DCs function a bit like spies; they venture onto the battlefield, steal little pieces of the invaders (antigens) and bring them back to the T cells. Then, with these antigens, the T cells have the information they need to recognize, target, and destroy the invading bacteria or viruses. After finding and presenting antigens, DCs undergo a process of maturation. 

Even when our body is in peacetime, dendritic cells mature, which helps prevent autoimmune reactions. This is called tolerogenic maturation. How it works, though, is a mystery. Until now. 

Victor Bosteels (VIB-UGent), co-first author of the study: "The pathways driving immunogenic maturation in response to infectious insults are well-characterized, but the signals that drive tolerogenic maturation during homeostasis are still poorly understood. So, we decided to map the molecular processes that drive tolerogenic DC maturation." 

Engulfment and cholesterol 

First, the researchers confirmed that, indeed, DCs undergo maturation without being exposed to infectious stimuli in mouse models. Digging deeper, they also figured out how that process takes place. 

Sandra Maréchal (VIB-UGent), co-first author: "We found that the engulfment of apoptotic cells – cells that die as a normal part of bodily maintenance, so to speak – is necessary and sufficient to trigger DC maturation. By using a single-cell technology called CITE Seq, we unraveled the genetic program behind this process and discovered that maturing DCs activate genes that help them remove cholesterol from inside their cell bodies." 
Summary figure of the findings. Created with BioRender.com.

With this knowledge of DC maturation in hand, the researchers took it one step further and they figured out how to mimic this process. By 'feeding' DCs empty lipid nanoparticles they could kickstart the maturation process, which suggests that the uptake of exogenous lipids, rather than the process of engulfment, is sufficient to drive the maturation program. 

Prof. Sophie Janssens (VIB-UGent), who led the study: "Our work has important implications for our understanding of the immune system in autoimmune conditions. We are hopeful that our research will lead to new insights into the role of dendritic cells in immune function, and ultimately to the development of new therapies for these and other diseases." 

Publication 

Bosteels, Maréchal, et al. LXR signaling controls homeostatic dendritic cell maturation. Science Immunology, 2023. 


Questions from patients  

A breakthrough in research is not the same as a breakthrough in medicine. The realizations of VIB researchers can form the basis of new therapies, but the development path still takes years. This can raise a lot of questions. That is why we ask you to please refer questions in your report or article to the email address that VIB makes available for this purpose: patienteninfo@vib.be. Everyone can submit questions concerning this and other medically-oriented research directly to VIB via this address. 


Gunnar De Winter

Gunnar De Winter

Science Communications Expert, VIB

 

 

Share

Latest stories

Website preview
Researchers identify a key biological tipping point in Alzheimer’s disease
Leuven, 4 June 2026 – Researchers from VIB, KU Leuven, the UK-DRI and Muna Therapeutics, funded by, among others, ERC, have uncovered a critical biological transition that may determine whether Alzheimer’s disease pathology leads to dementia. Studying brain tissue from older adults with and without cognitive decline, as well as cognitively healthy centenarians, the team identified distinct cellular programs and immune-cell states associated with disease progression and resilience. Their findings, published in Nature Medicine, suggest that changes in microglia—the brain’s resident immune cells—could represent an important target for future Alzheimer’s therapies.
press.vib.be
Website preview
Prof. Diether Lambrechts (KU Leuven/VIB) receives the Francqui-Collen Prize 2026
Brussels, June 2, 2026 – Prof. Dr. Diether Lambrechts (KU Leuven/VIB) and Prof. Dr. Patrice Cani (UCLouvain) are the laureates of the Francqui-Collen Prize 2026, one of the highest scientific distinctions in Belgium. Today, they receive the award from the hands of King Philippe. Prof. Lambrechts is being honored for his groundbreaking genetic research into cancer treatments, while Prof. Cani is recognized for his discoveries regarding the impact of gut bacteria on lifestyle-related diseases.
press.vib.be
Website preview
Comprehensive atlas maps dendritic cells across cancers
Brussels, 01 June 2026 — Researchers from VIB, VUB, and an international network of collaborators have created the most comprehensive single-cell atlas to date of tumor-associated dendritic cells. By integrating data from 14 mouse tumor models and 10 human cancer types, the study provides a detailed, cross-species view of how these key immune cells are organized and altered in cancer. This work, which appeared in Nature Communications, can guide the development of next-generation therapies.
press.vib.be

About VIB Press

VIB is an independent research institute that translates insights in biology into impactful innovations for society. Collaborating with the five Flemish universities, it conducts research in plant biology, cancer, neuroscience, microbiology, inflammatory diseases, artificial intelligence and more. VIB connects science with entrepreneurship and stimulates the growth of the Flemish biotech ecosystem. The institute contributes to solutions for societal challenges such as new methods for diagnostics and treatments, as well as innovations for agriculture. 

Learn more at www.vib.be.

Contact

Suzanne Tassierstraat 1 9052 Zwijnaarde

+32 9 244 66 11

press@vib.be

vib.be